These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7044013)

  • 21. Molsidomine, an effective long-acting anti-anginal drug.
    Balakumaran K; Hugenholtz PG; Tijssen JG; Chadha DR
    Eur Heart J; 1983 Sep; 4(9):655-61. PubMed ID: 6416844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.
    Messin R; Fenyvesi T; Carreer-Bruhwyler F; Crommen J; Chiap P; Hubert P; Dubois C; Famaey JP; Géczy J
    Eur J Clin Pharmacol; 2003 Jul; 59(3):227-32. PubMed ID: 12734607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Corvaton in the treatment of unstable angina pectoris].
    Mroczek-Wójtowicz J; Ilmurzyńska K; Janik-Strobel Z
    Wiad Lek; 1985 Nov; 38(21):1481-6. PubMed ID: 3913156
    [No Abstract]   [Full Text] [Related]  

  • 24. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molsidomin in stable stress angina].
    González Juanatey JR; Amaro Cendón A; Rubio Alvarez J; Gil de la Peña M
    Med Clin (Barc); 1985 Mar; 84(10):420-1. PubMed ID: 3838784
    [No Abstract]   [Full Text] [Related]  

  • 26. [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].
    Strasser R; Klepzig H; Ostrowski J; Resag K
    MMW Munch Med Wochenschr; 1983 Feb; 125(8):156-8. PubMed ID: 6405248
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of the acute administration of molsidomine in refractory congestive heart failure. A double-blind randomized non-invasive study].
    Coletta C; Galati A; Carunchio A; Salustri A; Bordi L; Fera MS
    G Ital Cardiol; 1986 Mar; 16(3):232-6. PubMed ID: 3755412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: a multicenter randomized double-blind crossover placebo-controlled trial.
    Messin R; Karpov Y; Baikova N; Bruhwyler J; Monseu MJ; Guns C; Géczy J
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):271-6. PubMed ID: 9475269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Corvaton in the ambulatory treatment of patients with angina pectoris].
    Bichan NA
    Klin Med (Mosk); 1984 Oct; 62(10):39-40. PubMed ID: 6549037
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of stress-induced angina pectoris and chronic heart failure with molsidomine].
    Beyerle A; Rudolph W
    Med Klin (Munich); 1986 Jan; 81(2):41-4. PubMed ID: 3537664
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of coronary heart disease with molsidomine].
    Kaliman J; Uhlir H; Klicpera M
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1761-2. PubMed ID: 6796846
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of an extended-release dosage form of molsidomine in patients with coronary heart disease.
    Ostrowski J; Gaul G; Voegele D; Brockmeier D; Resag K
    Eur J Clin Pharmacol; 1985; 28(5):611-3. PubMed ID: 3899679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molsidomine in the long-term treatment of angina pectoris].
    Blasini R; Brügmann U; Mannes A; Rudolph W
    Herz; 1982 Oct; 7(5):307-16. PubMed ID: 6818116
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term effects of molsidomine on exercise tolerance in patients with exertional angina pectoris.
    Kinoshita M; Sawamura M; Motomura M; Takayama Y; Kawaguchi Y; Kawakita S
    Jpn Circ J; 1983 Dec; 47(12):1398-405. PubMed ID: 6689183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synergic action of molsidomine and atenolol in patients with exertion angina. Cycloergometric study].
    Gimeno JV; Olagüe J; Bueno FJ; Tellols R; Martín G; Ferrer J
    Med Clin (Barc); 1984 Nov; 83(15):624-8. PubMed ID: 6549203
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative examinations of the effectiveness of Molsidomin and nitrates in angina pectoris].
    Lehmann HU; Ziegler G; Hochrein H
    Med Welt; 1980 Jul; 31(29-30):1099-103. PubMed ID: 6774198
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness of treating stenocardia patients with obzidan, corvaton and corinfar based on the indices of spirometric bicycle ergometry and of central hemodynamics].
    Korabel'shchikova NI; Rishko NV; Bichko MV
    Vrach Delo; 1985 Aug; (8):19-21. PubMed ID: 3840931
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rheological properties of blood in patients with stenocardia during treatment with obsidan, corvatone and corinfar].
    Korabel'shchikova NI; Bichko MV; Rishko NV
    Vrach Delo; 1985 Apr; (4):19-21. PubMed ID: 3892905
    [No Abstract]   [Full Text] [Related]  

  • 40. [A new family of anti-angina agents].
    Gourgon R; Russo-Marie F; Nicolas G; Witchitz S; Berdeaux A; Tartulier M
    Sem Hop; 1983 Oct; 59(37-38):2627-8. PubMed ID: 6314546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.